Publishing research using ab65089? Please let us know so that we can cite the reference in this datasheet.

ab65089 has been referenced in 3 publications.

  • Allen E  et al. Combined antiangiogenic and anti-PD-L1 therapy stimulates tumor immunity through HEV formation. Sci Transl Med 9:N/A (2017). PubMed: 28404866
  • Gray CM  et al. Noncanonical NF-?B signaling is limited by classical NF-?B activity. Sci Signal 7:ra13 (2014). PubMed: 24497610
  • Hehlgans T  et al. Activation of the lymphotoxin-beta receptor induces NFkappaB-dependent interleukin-6 and MIP-2 secretion in mouse fibrosarcoma cells. Eur Cytokine Netw 14:103-7 (2003). PubMed: 12957791

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

Sign up